Participation of nuclear localization signal 2 in the 3′-ETS domain of FLI1 in nuclear translocation of various chimeric EWS-FLI1 oncoproteins in Ewing tumor

International Journal of Oncology

Volumn 29, Issue 3, 2006, Pages 689-693

  Honsei, Norikazu ^a   Ikuta, Togo ^a   Kawana, Katsuyoshi ^a   Kaneko, Yasuhiko ^a   Kawajiri, Kaname ^a  

^a SAITAMA CANCER CENTER   (Japan)

Author keywords

Ewing tumor; EWS; EWS FLI1; FLI1; Nuclear localization signal

Indexed keywords

EWS FLI1 FUSION PROTEIN; EWS-FLI1 FUSION PROTEIN; FLI1 PROTEIN, HUMAN; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; NLF2 PROTEIN, HUMAN; ONCOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FLI 1;

ARTICLE; BONE TUMOR; CELL NUCLEUS; EWING SARCOMA; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN; METABOLISM; PHYSIOLOGY; PLASMID; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT; WESTERN BLOTTING;

BLOTTING, WESTERN; BONE NEOPLASMS; CELL NUCLEUS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; ONCOGENE PROTEINS, FUSION; PLASMIDS; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEIN C-FLI-1; RECOMBINANT FUSION PROTEINS; SARCOMA, EWING'S; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 33749367963     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.3.689     Document Type: Article

References (26)

1. Delattre O, Zucman J, Plougastel B, et al: Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359: 162-165, 1992.
2. Kover H: Ewing tumor biology: perspective for innovative treatment approaches. Adv Exp Med Biol 532: 27-37, 2003
3. Arvand A and Denny CT: Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene 20: 5747-5754, 2001.
4. Prasad DDK, Rao VN and Reddy ESP: Structure and expression of human FLI-1 gene. Cancer Res 52: 5833-5837, 1992.
5. Wasylyk B, Hahn SL and Giovane A: The Ets family of transcription factors. Eur J Biochem 211: 7-18, 1993.
6. Ohno T, Rao VR and Reddy SP: EWS/FLI-1 chimeric protein is a transcriptional activator. Cancer Res 53: 5859-5863, 1993.
7. May WA, Lessnick SL, Braun BS, et al: The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol Cell Biol 13: 7393-7398, 1993.
8. Braun BS, Frieden R, Lessnick SL and May WA: Denny CT. Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis. Mol Cell Biol 15: 4623-4630, 1995.
9. Hahm KB, Cho K, Lee C, et al: Repression of the gene encoding the TGF-β type II receptor is a major target of the EWS-FLI1 oncoprotein. Nat Genet 23: 222-227, 1999.
10. Zucman J, Melot T, Desmaze C, et al: Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J 12: 4481-4487, 1993.
11. Zoubek A, Dockhorn B, Delattre O, et al: Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol 14: 1245-1251, 1996.
12. de Alava E, Kawai A, Healey JH, et al: EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol 16: 1248-1255, 1998.
13. Ozeki T, Paulussen M, Poremba C, et al: Genetic imbalances revealed by comparative genomic hybridization in Ewing tumors. Genes Chromosomes Cancer 32: 164-171, 2001.
14. Felsch JS, Lane WS and Peralta EG: Tyrosine kinase pyk2 mediates G-protein-coupled receptor regulation of the Ewing sarcoma RNA-binding protein EWS. Curr Biol 9: 485-488, 1999.
15. Belyanskaya LL, Gehrig PM and Gehring H: Exposure on cell surface and extensive arginine methylation of Ewing sarcoma (EWS) protein. J Biol Chemist 278: 18681-18687, 2001.
16. Bailly RA, Bosselut R, Zucman J, et al: DNA-binding and transcriptional activation properties of the EWS-FLI1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol Cell Biol 14: 3230-3241, 1994.
17. Kim J, Lee K and Pelletier J: The DNA binding domains of the WT1 tumor suppressor gene product and chimeric EWS/WT1 oncoprotein are functionally distinct. Oncogene 16: 1021-1030, 1998.
18. Eguchi H, Ikuta T, Tachibana T, Yoneda Y and Kawajiri K: A nuclear localization signal of human aryl hydrocarbon receptor nuclear translocator/hypoxia-inducible factor 1β is a novel bipartite type recognized by the two components of nuclear pore-targeting complex. J Biol Chem 272: 17640-17647, 1997.
19. Ikuta T, Watanabe J and Kawajiri K: Characterization of the LxxLL motif in the aryl hydrocarbon receptor: effects on subcellular localization and transcriptional activity. J Biochem 131: 79-85, 2002.
20. Ladanyi M and Gerald W: Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res 54: 2837-2840, 1994.
21. Mattaj IW and Englmeier L: Nucleocytoplasmic transport: the soluble phase. Ann Rev Biochem 67: 265-306, 1998.
22. Nigg EA: Nucleocytoplasmic transport: signals, mechanisms and regulation. Nature 386: 779-787, 1997.
23. Boulukos KE, Pognonec P, Rabault B, Begue A and Ghysdael J: Definition of an Ets1 protein domain required for nuclear localization in cells and DNA-binding activity in vitro. Mol Cell Biol 9: 5718-5721, 1989.
24. Lin PP, Brody RI, Hamelin AC, Bradner JE, Healey JH and Ladanyi M: Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma. Cancer Res 59: 1428-1432, 1999.
25. de Alava E, Panizo A, Antonescu CR, Pardo-Mindan J, Huvos AG, Barr FG and Ladanyi M: Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma. Am J Pathol 156: 849-855, 2000.
26. Bandres E, Malumbres R, Escalada A, et al: Gene expression profile of Ewing sarcoma cell lines differing in their EWS-FLI1 fusion type. J Pediatr Hematol Oncol 27: 537-542, 2005.